Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Myocardial Infarction Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

24 recruiting trials for Myocardial Infarction. Eligibility criteria explained in plain English.

TrialFinderData lists 24 Myocardial Infarction clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 4 is the largest group at 40% (2 studies); the largest phase groups are Phase 4: 2, Phase 2: 1, Phase 3: 1, Early Phase 1: 1.

Research is led by John Sapp (2), ROM Technologies, INC (1), Brigham and Women's Hospital (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is ROMTech Portable Connect (device, 1 trial), followed by In-person cardiac rehabilitation, Telehealth cardiac rehabilitation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
24
Total Trials
24
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Track Myocardial Infarction trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05972070

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be...

Sponsor: ROM Technologies, INCEnrolling: 5001 location
RECRUITINGNCT01258231

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure....

Sponsor: Brigham and Women's HospitalEnrolling: 40003 locations
RECRUITINGNCT05933083

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling....

Sponsor: University of California, San FranciscoEnrolling: 5165 locations
RECRUITINGNCT04973579

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk...

Prospective, single-center, clinical registry of patients with symptomatic/critical carotid artery stenosis at risk of stroke coexisting with unstable or multivessel severe...

Sponsor: John Paul II Hospital, KrakowEnrolling: 501 location
RECRUITINGPhase 2NCT06564909

Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI

The study aims is to evaluate the efficacy and tolerability of L-Carnitine on biomarkers of myocardial reperfusion injury in patients with ST-segment elevation myocardial...

Sponsor: Ain Shams UniversityEnrolling: 761 location
RECRUITINGPhase 4NCT05262803

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction

Rationale: Heart attacks are a major cause of death and result from coronary blood clots that require acute coronary intervention and antithrombotic drugs to restore blood flow...

Sponsor: Rikke SorensenEnrolling: 28086 locations
RECRUITINGNCT05248165

Naples PCI Registry

The aim of the Naples PCI registry is to collect prospective data on baseline clinical, laboratory, and angiographic characteristics of patients undergoing PCI for acute or...

Sponsor: Federico II UniversityEnrolling: 50001 location
RECRUITINGNCT05272618

Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by...

Sponsor: Chonnam National University HospitalEnrolling: 1501 location
RECRUITINGPhase 3NCT07257198

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

In patients with a myocardial infarction (MI) treated medically alone, the objective of the PANTHEON trial is to evaluate if ticagrelor monotherapy reduces bleeding events,...

Sponsor: Montreal Heart InstituteEnrolling: 25701 location
RECRUITINGNCT04162171

Cohort Study - SBRT for VT Radioablation

Ventricular tachycardia (VT) contributes to over 350,000 sudden deaths each year in the US. Malignant VTs involve an electrical "short circuit" in the heart, formed by narrow...

Sponsor: John SappEnrolling: 121 location
RECRUITINGPhase 4NCT07617376

Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions

Patients hospitalized for acute cardiac conditions-including acute myocardial infarction, acute heart failure, pulmonary embolism, arrhythmias, and hypertensive...

Sponsor: Wroclaw Medical UniversityEnrolling: 4001 location
RECRUITINGNCT02791152

Effects of Physical Activity, Ambulatory Blood Pressure and Calcium Score on Cardiovascular Health in Normal People

A prospective cohort of relatively healthy individuals, using comprehensive clinical information, advanced imaging (including cardiac MRI), cardiovascular exercise physiology,...

Sponsor: National Heart Centre SingaporeEnrolling: 10001 location
RECRUITINGNCT04672551

EMDR Treatment in PTSD Following Cardiac Events

Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress...

Sponsor: University of ZurichEnrolling: 601 location
RECRUITINGEarly Phase 1NCT02973633

Diffusion MRI in Heart Failure

The development of symptomatic heart failure is frequently preceded by a pre-clinical period of structural remodeling in the heart. The remodeling process driving this transition,...

Sponsor: Massachusetts General HospitalEnrolling: 1601 location
RECRUITINGNCT03713866

Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia

Ventricular tachycardia (VT) contributes to over 350,000 sudden deaths each year in the US. Malignant VTs involve an electrical "short circuit" in the heart, formed by narrow...

Sponsor: John SappEnrolling: 201 location
RECRUITINGNCT02355457

Biomarkers in Acute Cardiac Care

The primary aim of the study is to investigate new cardiac biomarkers and algorithms to diagnose acute coronary syndrome in patients with suspected acute myocardial infarction.

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 50001 location
RECRUITINGNCT06955936

Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction

Cardiogenic shock is the most severe manifestation of acute heart failure and remains the leading cause of death in patients hospitalised with acute myocardial infarction....

Sponsor: Efferon JSCEnrolling: 601 location
RECRUITINGNCT05937685

Reducing Blood Pressure in Patients With High Cardiovascular Risk

BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department...

Sponsor: University of Southern CaliforniaEnrolling: 5464 locations
RECRUITINGNCT04988672

OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting...

The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with...

Sponsor: Luzerner KantonsspitalEnrolling: 40001 location
RECRUITINGNCT04458883

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

The main aim of the study is to build and test a cardiac-specific coil purposely assembled in house to suit the FFC-MRI whole-body prototype and to test if it could be used for...

Sponsor: University of AberdeenEnrolling: 1502 locations
RECRUITINGNCT06857838

Myocardialbridge Bypass Graft Surgery Efficacy Verification

Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected...

Sponsor: Xi'an International Medical Center HospitalEnrolling: 5001 location
RECRUITINGNCT06007950

Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health

The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer...

Sponsor: Universiti Teknologi MaraEnrolling: 481 location
RECRUITINGNCT06701968

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Diet can play a key role in atherosclerosis and coronary heart disease (CHD), but little interventional data exists, and the mediators of possible anti-atherosclerotic effects of...

Sponsor: Uppsala UniversityEnrolling: 1501 location
RECRUITINGNCT04950218

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether...

Sponsor: Herlev and Gentofte HospitalEnrolling: 10001 location

Frequently Asked Questions

There are currently 24 clinical trials for Myocardial Infarction, with 24 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Myocardial Infarction, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Myocardial Infarction, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.